[Corrigendum] ND09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCRABL signaling.
Oncol Rep
; 49(5)2023 May.
Article
en En
| MEDLINE
| ID: mdl-36896777
ABSTRACT
Subsequently to the publication of this paper, the authors have realized that an error was made during the compilation of Fig. 2A as it appeared on p. 4. Essentially, the partial Q23 images of the '1.56 µm' group were inadvertently copied across to the Q23 images of the '3.12 µm' group, leading to the cell number of the Q23 quadrant being the same for both the 1.56 µm and the 3.12 µm groups, and also leading the total cell number of the 3.12 µm group being calculated as 106.97%, which was clearly incorrect (the total percentage should have added up to 100%). The corrected version of Fig. 2, showing the correct data for the Q23 images in the '3.12 µm' group, is shown on the next page. Note that this error did not significantly affect the results or the conclusions reported in this paper, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them this opportunity to publish a corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 46 136, 2021; DOI 10.3892/or.2021.8087].
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Oncol Rep
Asunto de la revista:
NEOPLASIAS
Año:
2023
Tipo del documento:
Article